Charles River Laboratories International, Inc. (CRL)
224.03
-2.74
(-1.21%)
USD |
NYSE |
Jan 22, 16:00
224.53
+0.50
(+0.22%)
Pre-Market: 06:09
Charles River Laboratories International Shareholders Equity (Quarterly): 3.405B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Johnson & Johnson | -- |
| UnitedHealth Group, Inc. | 95.79B |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.514B |
| Total Liabilities (Quarterly) | 4.063B |
| Debt to Equity Ratio | 0.7727 |
| Current Ratio | 1.366 |
| Net Debt Paydown Yield | 0.55% |